期刊
MOLECULAR BRAIN
卷 13, 期 1, 页码 -出版社
BMC
DOI: 10.1186/s13041-020-00658-6
关键词
FTD3; CHMP2B; iPSC-derived neuron; Glucose metabolism; Glutamate; Glutamine; GC-MS; GDH; PAG; GS
资金
- EU FP7 Marie Curie Industry-Academia Partnerships and Pathways (IAPP) grant (STEMMAD) [PIAPP-GA-2012-324451]
- Innovation Fund Denmark [4108-00008B, 4096-00001B]
- China Scholarship Council
- Ministry of Science, Technology and Innovation of Mexico
Frontotemporal dementia (FTD) is amongst the most prevalent early onset dementias and even though it is clinically, pathologically and genetically heterogeneous, a crucial involvement of metabolic perturbations in FTD pathology is being recognized. However, changes in metabolism at the cellular level, implicated in FTD and in neurodegeneration in general, are still poorly understood. Here we generate induced human pluripotent stem cells (hiPSCs) from patients carrying mutations in CHMP2B(FTD3) and isogenic controls generated via CRISPR/Cas9 gene editing with subsequent neuronal and glial differentiation and characterization. FTD3 neurons show a dysregulation of glutamate-glutamine related metabolic pathways mapped by C-13-labelling coupled to mass spectrometry. FTD3 astrocytes show increased uptake of glutamate whilst glutamate metabolism is largely maintained. Using quantitative proteomics and live-cell metabolic analyses, we elucidate molecular determinants and functional alterations of neuronal and glial energy metabolism in FTD3. Importantly, correction of the mutations rescues such pathological phenotypes. Notably, these findings implicate dysregulation of key enzymes crucial for glutamate-glutamine homeostasis in FTD3 pathogenesis which may underlie vulnerability to neurodegeneration.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据